SPONSOR
Peking University First Hospital
Total Trials
11
Recruiting
11
Phases
Phase 1
Conditions studied: Atopic Dermatitis EczemaPrurigo NodularisChronic Kidney Disease (Stages 3b-5)Acute Myocardial InfarctionCoronary Artery DiseaseType 1 Diabetes MellitusDeep LearningUltrasoundBladder CancerAcute Myeloid Leukemia (AML)
Peking University First Hospital is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Atopic Dermatitis Eczema, Prurigo Nodularis, Chronic Kidney Disease (Stages 3b-5), Acute Myocardial Infarction.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Peking University First Hospital
How many clinical trials has Peking University First Hospital sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Peking University First Hospital, of which 11 are actively recruiting participants. These trials cover conditions including Atopic Dermatitis Eczema, Prurigo Nodularis, Chronic Kidney Disease (Stages 3b-5). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Peking University First Hospital research focus on?
Peking University First Hospital clinical trials span Atopic Dermatitis Eczema, Prurigo Nodularis, Chronic Kidney Disease (Stages 3b-5), Acute Myocardial Infarction, Coronary Artery Disease, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Peking University First Hospital clinical trial?
To participate in a Peking University First Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peking University First Hospital trials with current recruitment status updated daily.
Clinical Trials by Peking University First Hospital
NCT05316805
Recruiting
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
Atopic Dermatitis Eczema
NCT06901960
Recruiting
Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5
Chronic Kidney Disease (Stages 3b-5)
NCT06489080
Recruiting
Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction
Acute Myocardial Infarction
NCT07144696
Recruiting
Study on the Improvement of Metabolic Indicators in Type 1 Diabetes Patients
Type 1 Diabetes Mellitus
NCT07111364
Recruiting
Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, Ambispective Cohort Study
Deep Learning
NCT06641648 Phase 1
Recruiting
A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined With Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.
Acute Myeloid Leukemia (AML)
NCT07015138
Recruiting
Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer
Prostate Cancer
NCT06842264
Recruiting
The Development and Validation of MRI-AI-based Predictive Models for csPCa
Prostate Cancer
NCT06669429 Phase 1
Recruiting
A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Healthy Subjects
Dyslipidemia
NCT06841211
Recruiting
Optimizing Prostate Biopsy Schemes in Men With Multiple MRI Visible Lesions
Prostate Cancer
NCT06392737
Recruiting
Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis
Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology